Home/Filings/4/0001437749-22-013460
4//SEC Filing

Zheng Yenyou 4

Accession 0001437749-22-013460

CIK 0001389545other

Filed

May 23, 8:00 PM ET

Accepted

May 24, 7:31 PM ET

Size

6.4 KB

Accession

0001437749-22-013460

Insider Transaction Report

Form 4
Period: 2022-05-21
Zheng Yenyou
Director
Transactions
  • Exercise/Conversion

    Common Stock

    2022-05-21+30,00030,000 total
  • Exercise/Conversion

    Restricted Stock Units

    2022-05-2130,00030,000 total
    Common Stock (30,000 underlying)
Footnotes (1)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested on the one year anniversary of the date of grant.

Issuer

NovaBay Pharmaceuticals, Inc.

CIK 0001389545

Entity typeother

Related Parties

1
  • filerCIK 0001330748

Filing Metadata

Form type
4
Filed
May 23, 8:00 PM ET
Accepted
May 24, 7:31 PM ET
Size
6.4 KB